Alterity Therapeutics Limited Net Asset Quality Index
Alterity Therapeutics Limited net asset quality index. Alterity Therapeutics Limited (PBN) has a Net Asset Quality Index of 95.3% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €56.92 Million minus total liabilities of €2.65 Million yields net assets of €54.27 Million. A higher index indicates a stronger, lower-leverage balance sheet. See PBN net asset value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Alterity Therapeutics Limited (2014–2025)
Net asset quality index of Alterity Therapeutics Limited from 2014 to 2025. This chart shows how Alterity Therapeutics Limited's Net Asset Quality Index has evolved across 12 annual periods from 2014 to 2025. As of December 2025, the index stands at 95.3%, representing net assets of €54.27 Million against total assets of €56.92 Million EUR. Check Alterity Therapeutics Limited (PBN) strategic investment index to assess the company's strategic physical and investment asset allocation.
Alterity Therapeutics Limited Net Asset Quality Index by Year (2014–2025)
Alterity Therapeutics Limited net asset quality index by year from 2014 to 2025. The table below presents the year-by-year Net Asset Quality Index for Alterity Therapeutics Limited from 2014 to 2025, covering 12 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see PBN company net worth.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 92.1% | €42.40 Million | €46.03 Million | €3.62 Million | ▲ +20.4 pp |
| 2024 | 71.8% | €13.80 Million | €19.22 Million | €5.43 Million | ▼ -11.7 pp |
| 2023 | 83.5% | €22.81 Million | €27.32 Million | €4.50 Million | ▼ -2.2 pp |
| 2022 | 85.8% | €35.47 Million | €41.36 Million | €5.89 Million | ▼ -5.0 pp |
| 2021 | 90.7% | €30.47 Million | €33.59 Million | €3.12 Million | ▲ +18.6 pp |
| 2020 | 72.2% | €7.15 Million | €9.91 Million | €2.76 Million | ▼ -11.0 pp |
| 2019 | 83.1% | €16.55 Million | €19.91 Million | €3.36 Million | ▼ -2.7 pp |
| 2018 | 85.9% | €16.08 Million | €18.73 Million | €2.64 Million | ▼ -7.8 pp |
| 2017 | 93.7% | €23.69 Million | €25.28 Million | €1.59 Million | ▲ +0.7 pp |
| 2016 | 93.0% | €31.37 Million | €33.73 Million | €2.36 Million | ▼ -0.5 pp |
| 2015 | 93.5% | €39.11 Million | €41.83 Million | €2.72 Million | ▲ +3.0 pp |
| 2014 | 90.5% | €37.69 Million | €41.64 Million | €3.95 Million | — |